News | March 04, 2011

Boston Scientific Completes Acquisition of Atritech

Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a definitive merger agreement announced on Jan. 19, 2011.

Atritech's Watchman Left Atrial Appendage Closure Technology gives Boston Scientific a product designed for atrial fibrillation patients with high stroke risk. Atrial fibrillation patients are prone to developing blood clots in the left atrial appendage (LAA) that can dislodge and block circulation to the brain, resulting in a stroke. The device is designed to close the LAA, thereby preventing clots from being dislodged into circulation.

Atritech has completed PROTECT-AF, an 800-patient randomized clinical trial that demonstrated a 38 percent relative risk reduction for stroke, cardiovascular death and systemic embolism compared to long-term warfarin therapy. Atritech is currently enrolling patients in the PREVAIL study, a confirmatory study designed to gain U.S. Food and Drug Administration (FDA) approval. The Watchman device is CE Marked and was commercialized outside the United States in 2009.

Under the acquisition agreement, Boston Scientific purchased all outstanding Atritech shares for a total of $100 million. Additional payments of up to $275 million are contingent upon achievement of specified regulatory and revenue-based criteria through 2015.

For more information: www.bostonscientific.com, www.atritech.net

Related Content

The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.

The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.

News | Stroke | July 07, 2021
July 7, 2021 – Robocath, a company that designs, develops and commercializes...
Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

News | Stroke | April 07, 2021
April 7, 2021 — Market research firm GlobalData's new report,...
Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging. #RSNA20 #RSNA2020

Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.
 

News | Stroke | December 01, 2020
December 1, 2020 – Medical imaging ...
A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.

A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.

News | Stroke | July 09, 2020
July 9, 2020 — The Society for Vascular Surgery (SVS) has release
Synaptive Medical, a leader in robotic surgical visualization, announced today the company has secured approval from Health Canada for Evry, the company’s superconducting, head magnetic resonance imaging (MRI) system
News | Stroke | February 20, 2020
February 20, 2020 — Synaptive Medical, a leader in ro
New Algorithm Expands Neurologists' Ability to Assess for Clot-removing Procedure
News | Stroke | October 18, 2019
An algorithm developed by faculty at The University of Texas Health Science Center at Houston (UTHealth) can help...
Mobile Stroke Unit Gets Patients Quicker Treatment Than Traditional Ambulance

Image courtesy of UTHealth McGovern Medical School

News | Stroke | August 16, 2019
Every second counts for stroke patients, as studies show they can lose up to 27 million brain cells per minute....
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Stroke | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Stroke | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging, ...
Videos | Stroke | May 16, 2019
This is an example of a carotid artery reporting module from Change Healthcare at...